05/05/2025 3:47 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:49 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:50 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:52 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:53 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:54 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 5:26 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 5:24 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 4:10 PM | Kiniksa Pharmaceuticals (Subject) Moat Ross (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025 4:11 PM | Kiniksa Pharmaceuticals (Subject) Ragosa Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025 3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
04/29/2025 6:40 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2025 6:47 PM | BlackRock, Inc. (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025 3:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2025 3:44 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2025 4:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/16/2025 3:38 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2025 3:39 PM | Kiniksa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/09/2025 3:41 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:42 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:43 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:44 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:45 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:45 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 5:57 PM | Kiniksa Pharmaceuticals (Subject) TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/03/2025 4:06 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2025 3:52 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/24/2025 3:35 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:48 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:49 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:50 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:51 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:52 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2025 4:53 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 4:29 PM | Kiniksa Pharmaceuticals (Subject) Ragosa Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025 3:37 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 3:38 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 3:47 PM | Kiniksa Pharmaceuticals (Subject) Megna Michael R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025 3:37 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 4:13 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025 3:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
02/25/2025 3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/25/2025 6:31 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 2:45 PM | Fairmount Funds Management LLC (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025 4:37 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 3:42 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:27 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025 6:34 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 3:45 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 4:17 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 3:34 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2024 6:14 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:25 PM | Kiniksa Pharmaceuticals (Subject) Ragosa Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 4:13 PM | Kiniksa Pharmaceuticals (Subject) Megna Michael R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 4:50 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 3:32 PM | HHLR ADVISORS, LTD. (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024 3:30 PM | Kiniksa Pharmaceuticals (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024 3:11 PM | Kiniksa Pharmaceuticals (Subject) Patel Sanj K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 3:14 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024 6:31 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/21/2024 3:11 PM | BlackRock, Inc. (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SC 13G | |
10/17/2024 3:35 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 3:57 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 4:29 PM | BAKER BROS. ADVISORS LP (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/08/2024 4:08 PM | Boyd Meta Cantey (Reporting) Kiniksa Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/08/2024 3:40 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:14 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Kiniksa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:39 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/23/2024 4:02 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 7:57 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 7:51 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 7:52 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 7:53 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 7:55 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 7:42 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 4:16 PM | Kiniksa Pharmaceuticals (Subject) Paolini John F. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 4:17 PM | Kiniksa Pharmaceuticals (Subject) Moat Ross (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024 3:36 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 4:17 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:31 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:32 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:33 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:10 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024 6:54 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/04/2024 11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
07/04/2024 11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/30/2024 11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/28/2024 4:29 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/28/2024 4:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 15-15D | |
06/28/2024 4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/28/2024 4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
06/28/2024 4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:24 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:24 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:25 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/27/2024 8:34 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/25/2024 3:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:27 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 3:35 PM | Kiniksa Pharmaceuticals (Issuer) Quart Barry D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |